España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
marac 8 mg/dispensacion solucion oral
cyathus exquirere pharmaforschungs gmbh - betahistina dihidrocloruro - excipientes: glicerol,alcohol etilico (etanol),benzoato de sodio (e 211),sacarina sodica - preparados contra el vÉrtigo - preparados contra el vértigo - betahistina
Perú -
español -
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
betina 16 mg comprimido
eurofarma peru s.a.c. - droguerÍa - diclorhidrato de betahistina; - comprimido - por comprimido - - betahistina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
betahistina accord 16 mg comprimidos recubiertos con pelicula efg
accord healthcare, s.l.u - betahistina dihidrocloruro - excipientes: lactosa monohidrato,almidon de maiz,almidon de maiz - preparados contra el vÉrtigo - preparados contra el vértigo - betahistina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
betahistina accord 8 mg comprimidos recubiertos con pelicula efg
accord healthcare, s.l.u - betahistina dihidrocloruro - excipientes: lactosa monohidrato,almidon de maiz,almidon de maiz - preparados contra el vÉrtigo - preparados contra el vértigo - betahistina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
betahistina stadafarma 24 mg comprimidos efg
laboratorio stada s.l. - betahistina dihidrocloruro - comprimido - 24 mg - betahistina dihidrocloruro 24 mg - betahistina
Unión Europea -
español -
EMA (European Medicines Agency)
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - agentes antineoplásicos - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
Unión Europea -
español -
EMA (European Medicines Agency)
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioedemas, hereditario - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
Unión Europea -
español -
EMA (European Medicines Agency)
sapropterin dipharma
dipharma arzneimittel gmbh - dihidrocloruro de sapropterina - fenilcetonurias - otros tracto alimentario y metabolismo de los productos, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
Unión Europea -
español -
EMA (European Medicines Agency)
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinoma, pulmón no microcítico - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
Perú -
español -
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
betaserc 16mg tableta
farmindustria s.a. - diclorhidrato de betahistina; - tableta - por tableta; diclorhidrato de betahistina 16.000000 mg; - betahistina